Patient Portal

Brad S. Kahl, MD

Professor, Medicine
Division of Oncology

Director, Lymphoma Program

Specialty Areas

Lymphoma
Leukemia
Hematologic Malignancies

Board Certifications

Internal Medicine
Hematology

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Lymphoma, CLL

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129
Phone: 314-747-7222

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110
Phone: 314-747-7222

Education

Education

Fellowship, Hematology: University of Wisconsin-Madison, Madison, WI 2000
Chief Medical Resident: University of Wisconsin-Madison, Madison, WI 1998
Residency, Internal Medicine: University of Wisconsin-Madison, Madison, WI 1997
Medical Degree: Tufts University School of Medicine, Boston, MA 1994
Bachelor of Science: University of Wisconsin-Madison, Madison, WI 1989

Publication & Research

Publication & Research

Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era.
King RL, Nowakowski GS, Witzig TE, Scott DW, Little RF, Hong F, Gascoyne RD, Kahl BS, Macon WR
Blood Cancer J. 2018 Feb 28; 8(3)27. doi: 10.1038/s41408-018-0064-9.

PMID:
    29531316
    [PubMed - in process]
Related citations


High-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements with diffuse large B-cell lymphoma morphology.
Scott DW, King RL, Staiger AM, Ben-Neriah S, Jiang A, Horn H, Mottok A, Farinha P, Slack GW, Ennishi D, Schmitz N, Pfreundschuh M, Nowakowski GS, Kahl BS, Connors JM, Gascoyne RD, Ott G, Macon WR, Rosenwald A
Blood. 2018 May 3; 131(18)2060-2064. doi: 10.1182/blood-2017-12-820605.

PMID:
    29475959
    [PubMed - in process]
Related citations


Follicular lymphoma: are we ready for a risk-adapted approach?
Kahl BS
Hematology Am Soc Hematol Educ Program. 2017 Dec 8; 2017(1)358-364. doi: 10.1182/asheducation-2017.1.358.

PMID:
    29222279
    [PubMed - in process]
Related citations


VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Chang JE, Carmichael LL, Kim K, Peterson C, Yang DT, Traynor AM, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS
Clin Lymphoma Myeloma Leuk. 2018 Jan; 18(1)e61-e67. doi: 10.1016/j.clml.2017.10.006.

PMID:
    29191715
    [PubMed - in process]
Related citations


NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells.
Li Y, Wang F, Lu L, Zhu F, Huang S, Nomie K, Zhang L, Yang DT, Huang W, Kahl BS, Safe S, Wang M, Rui L
Blood Cancer J. 2017 Nov 23; 7(12)632. doi: 10.1038/s41408-017-0005-z.

PMID:
    29167454
    [PubMed - in process]
Related citations


Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Wierda WG, Byrd JC, Abramson JS, Bhat S, Bociek G, Brander D, Brown J, Chanan-Khan A, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lancet J, Ma S, Malek S, Mosse C, Shadman M, Siddiqi T, Stephens D, Wagner N, Zelenetz AD, Dwyer MA, Sundar H
J Natl Compr Canc Netw. 2017 Nov; 15(11)1414-1427. doi: 10.6004/jnccn.2017.0165.

PMID:
    29118233
    [PubMed - in process]
Related citations


Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM
Cancer. 2018 Jan 1; 124(1)136-144. doi: 10.1002/cncr.30979.

PMID:
    28902390
    [PubMed - indexed for MEDLINE]
Related citations


Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies.
Cohen JB, Zain JM, Kahl BS
Am Soc Clin Oncol Educ Book. 2017; 37512-525. doi: 10.14694/EDBK_175448.

PMID:
    28561694
    [PubMed - indexed for MEDLINE]
Related citations


Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
Gopal AK, Kahl BS, Flowers CR, Martin P, Ansell SM, Abella-Dominicis E, Koh B, Ye W, Barr PM, Salles GA, Friedberg JW
Blood. 2017 Jun 1; 129(22)3037-3039. doi: 10.1182/blood-2016-12-757740.

PMID:
    28325864
    [PubMed - indexed for MEDLINE]
Related citations


Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM
Clin Lymphoma Myeloma Leuk. 2017 Apr; 17(4)193-200. doi: 10.1016/j.clml.2016.10.001.

PMID:
    28209473
    [PubMed - indexed for MEDLINE]
Related citations


Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop.
Kahl BS, Dreyling M, Gordon LI, Quintanilla-Martinez L, Sotomayor EM
Leuk Lymphoma. 2017 Jul; 58(7)1561-1569. doi: 10.1080/10428194.2017.1283036.

PMID:
    28140709
    [PubMed - indexed for MEDLINE]
Related citations


Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.
Davids MS, Roberts AW, Seymour JF, Pagel JM, Kahl BS, Wierda WG, Puvvada S, Kipps TJ, Anderson MA, Salem AH, Dunbar M, Zhu M, Peale F, Ross JA, Gressick L, Desai M, Kim SY, Verdugo M, Humerickhouse RA, Gordon GB, Gerecitano JF
J Clin Oncol. 2017 Mar 10; 35(8)826-833. doi: 10.1200/JCO.2016.70.4320.

PMID:
    28095146
    [PubMed - indexed for MEDLINE]
Related citations


Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.
Spurgeon SE, Till BG, Martin P, Goy AH, Dreyling MP, Gopal AK, LeBlanc M, Leonard JP, Friedberg JW, Baizer L, Little RF, Kahl BS, Smith MR
J Natl Cancer Inst. 2017 Jan; 109(1)pii: djw263. doi: 10.1093/jnci/djw263.

PMID:
    28040733
    [PubMed - indexed for MEDLINE]
Related citations


Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.
Diefenbach CS, Connors JM, Friedberg JW, Leonard JP, Kahl BS, Little RF, Baizer L, Evens AM, Hoppe RT, Kelly KM, Persky DO, Younes A, Kostakaglu L, Bartlett NL
J Natl Cancer Inst. 2017 Apr; 109(4)pii: djw249. doi: 10.1093/jnci/djw249.

PMID:
    28040700
    [PubMed - indexed for MEDLINE]
Related citations


Recommendations for Clinical Trial Development in Follicular Lymphoma.
Maddocks K, Barr PM, Cheson BD, Little RF, Baizer L, Kahl BS, Leonard JP, Fowler N, Gordon LI, Link BK, Friedberg JW, Ansell SM
J Natl Cancer Inst. 2017 Mar; 109(3)pii: djw255. doi: 10.1093/jnci/djw255.

PMID:
    28040699
    [PubMed - indexed for MEDLINE]
Related citations


T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment.
Casulo C, O'Connor O, Shustov A, Fanale M, Friedberg JW, Leonard JP, Kahl BS, Little RF, Pinter-Brown L, Advani R, Horwitz S
J Natl Cancer Inst. 2017 Feb; 109(2)doi: 10.1093/jnci/djw248.

PMID:
    28040682
    [PubMed - indexed for MEDLINE]
Related citations


The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
Boyiadzis M, Bishop MR, Abonour R, Anderson KC, Ansell SM, Avigan D, Barbarotta L, Barrett AJ, Van Besien K, Bergsagel PL, Borrello I, Brody J, Brufsky J, Cairo M, Chari A, Cohen A, Cortes J, Forman SJ, Friedberg JW, Fuchs EJ, Gore SD, Jagannath S, Kahl BS, Kline J, Kochenderfer JN, Kwak LW, Levy R, de Lima M, Litzow MR, Mahindra A, Miller J, Munshi NC, Orlowski RZ, Pagel JM, Porter DL, Russell SJ, Schwartz K, Shipp MA, Siegel D, Stone RM, Tallman MS, Timmerman JM, Van Rhee F, Waller EK, Welsh A, Werner M, Wiernik PH, Dhodapkar MV
J Immunother Cancer. 2016; 490. doi: 10.1186/s40425-016-0188-z.

PMID:
    28018601
    [PubMed]
Related citations


RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.
Chen RW, Li H, Bernstein SH, Kahwash S, Rimsza LM, Forman SJ, Constine L, Shea TC, Cashen AF, Blum KA, Fenske TS, Barr PM, Phillips T, Leblanc M, Fisher RI, Cheson BD, Smith SM, Faham M, Wilkins J, Leonard JP, Kahl BS, Friedberg JW
Br J Haematol. 2017 Mar; 176(5)759-769. doi: 10.1111/bjh.14480.

PMID:
    27992063
    [PubMed - indexed for MEDLINE]
Related citations


Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
Nowakowski GS, Blum KA, Kahl BS, Friedberg JW, Baizer L, Little RF, Maloney DG, Sehn LH, Williams ME, Wilson WH, Leonard JP, Smith SM
J Natl Cancer Inst. 2016 Dec; 108(12)pii: djw257. doi: 10.1093/jnci/djw257.

PMID:
    27986884
    [PubMed - indexed for MEDLINE]
Related citations


General Biomarker Recommendations for Lymphoma.
Rimsza L, Fedoriw Y, Staudt LM, Melnick A, Gascoyne R, Crump M, Baizer L, Fu K, Hsi E, Chan JW, McShane L, Leonard JP, Kahl BS, Little RF, Friedberg JW, Kostakoglu L
J Natl Cancer Inst. 2016 Dec; 108(12)pii: djw250.

PMID:
    27986882
    [PubMed - indexed for MEDLINE]
Related citations

Areas of Research Interest

Developing new and better treatment approaches to lymphoma and chronic lymphocytic leukemia.